A functional and structural basis for TCR cross-reactivity in multiple sclerosis

被引:426
作者
Lang, HLE
Jacobsen, H
Ikemizu, S
Andersson, C
Harlos, K
Madsen, L
Hjorth, P
Sondergaard, L
Svejgaard, A
Wucherpfennig, K
Stuart, DI
Bell, JI
Jones, EY
Fugger, L
机构
[1] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England
[2] John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England
[3] Aarhus Univ Hosp, Skejby Sygehus, Dept Clin Immunol, DK-8200 Aarhus N, Denmark
[4] Rigshosp, Dept Clin Immunol, DK-2200 Copenhagen N, Denmark
[5] Aarhus Univ, Inst Mol & Struct Biol, DK-8000 Aarhus C, Denmark
[6] Univ Copenhagen, Inst Mol Biol, DK-1353 Copenhagen K, Denmark
[7] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
基金
英国医学研究理事会;
关键词
D O I
10.1038/ni835
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The multiple sclerosis (MS)-associated HLA major histocompatibility complex (MHC) class II alleles DRB1*1501, DRB5*0101 and DQB1*0602 are in strong linkage disequilibrium, making it difficult to determine which is the principal MS risk gene. Here we show that together the DRB1 and DRB5 loci may influence susceptibility to MS. We demonstrate that a T cell receptor (TCR) from an MS patient recognized both a DRB1*1501-restricted myelin basic protein (MBP) and DRB5*0101-restricted Epstein-Barr virus (EBV) peptide. Crystal structure determination of the DRB5*0101-EBV peptide complex revealed a marked degree of structural equivalence to the DRB1*1501-MBP peptide complex at the surface presented for TCR recognition. This provides structural evidence for molecular mimicry involving HLA molecules. The structural details suggest an explanation for the preponderance of MHC class II associations in HLA-associated diseases.
引用
收藏
页码:940 / 943
页数:4
相关论文
共 36 条
[1]   Chlamydia infections and heart disease linked through antigenic mimicry [J].
Bachmaier, K ;
Neu, N ;
de la Maza, LM ;
Pal, S ;
Hessel, A ;
Penninger, JM .
SCIENCE, 1999, 283 (5406) :1335-1339
[2]   Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR [J].
Basu, D ;
Horvath, S ;
Matsumoto, I ;
Fremont, DH ;
Allen, PM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (11) :5788-5796
[3]   3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39
[4]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[5]   Prospective study on the relationship between infections and multiple sclerosis exacerbations [J].
Buljevac, D ;
Flack, HZ ;
Hop, WCJ ;
Hijdra, D ;
Laman, JD ;
Savelkoul, HFJ ;
van der Meché, FGA ;
van Doorn, PA ;
Hintzen, RQ .
BRAIN, 2002, 125 :952-960
[6]   Further additions to MolScript version 1.4, including reading and contouring of electron-density maps [J].
Esnouf, RM .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1999, 55 :938-940
[7]   THE MULTIPLE-SCLEROSIS-ASSOCIATED AND NARCOLEPSY-ASSOCIATED HLA CLASS-II HAPLOTYPE INCLUDES THE DRB5-ASTERISK-0101 ALLELE [J].
FOGDELL, A ;
HILLERT, J ;
SACHS, C ;
OLERUP, O .
TISSUE ANTIGENS, 1995, 46 (04) :333-336
[8]   Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein [J].
Gauthier, L ;
Smith, KJ ;
Pyrdol, J ;
Kalandadze, A ;
Strominger, JL ;
Wiley, DC ;
Wucherpfennig, KW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11828-11833
[9]   THE STRUCTURE OF AN INTERMEDIATE IN CLASS-II MHC MATURATION - CLIP BOUND TO HLA-DR3 [J].
GHOSH, P ;
AMAYA, M ;
MELLINS, E ;
WILEY, DC .
NATURE, 1995, 378 (6556) :457-462
[10]   Structure of a covalently stabilized complex of a human αβ T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1 [J].
Hennecke, J ;
Carfi, A ;
Wiley, DC .
EMBO JOURNAL, 2000, 19 (21) :5611-5624